- 米国企業
- RESMED INC
RESMED INCRMD
時価総額
$357.4億
PER
| 2012年 6月30日 | 2013年 6月30日 | 2014年 6月30日 | 2015年 6月30日 | 2016年 6月30日 | 2017年 6月30日 | 2018年 6月30日 | 2019年 6月30日 | 2020年 6月30日 | 2021年 6月30日 | 2022年 6月30日 | 2023年 6月30日 | |
| Sleep And Respiratory | - | - | - | - | - | - | - | - | 2,602 | 2,823 | 3,177 | 3,725 |
| Software as a Service | - | - | - | - | - | - | - | - | - | - | - | 498 |
| Net revenue | 1,369 | 1,514 | 1,555 | 1,679 | 1,839 | 2,067 | 2,340 | 2,607 | 2,957 | 3,197 | 3,578 | 4,223 |
| Sleep And Respiratory | - | - | - | - | - | - | - | - | 1,068 | 1,177 | 1,365 | 1,663 |
| Software as a Service | - | - | - | - | - | - | - | - | - | - | - | 174 |
| Cost of sales (exclusive of amortization shown separately below) | - | - | - | - | - | - | - | - | 1,190 | 1,313 | 1,514 | 1,837 |
| Sleep And Respiratory | - | - | - | - | - | - | - | - | 9 | 5 | 4 | 5 |
| Software as a Service | - | - | - | - | - | - | - | - | - | - | - | 25 |
| Amortization of Intangible Assets | 14 | - | - | - | - | - | - | - | 50 | 45 | 40 | 30 |
| Total cost of sales | - | - | - | - | - | - | - | 1,070 | 1,239 | 1,358 | 1,554 | 1,867 |
| Gross profit | 821 | 941 | 990 | 1,011 | 1,066 | 1,202 | 1,362 | 1,537 | 1,718 | 1,839 | 2,024 | 2,356 |
| Selling, general, and administrative | 402 | 431 | 450 | 479 | 488 | 554 | 600 | 645 | 677 | 670 | 739 | 874 |
| Research and development | 110 | 120 | 118 | 115 | 119 | 144 | 155 | 181 | 202 | 225 | 254 | 288 |
| Amortization of acquired intangible assets | - | - | - | - | - | - | - | - | - | - | - | 42 |
| Restructuring expenses (note 18) | - | - | - | - | - | - | - | - | - | - | - | 9 |
| Acquisition related expenses | - | - | - | - | - | 10 | - | 6 | - | - | - | 11 |
| Total operating expenses | 526 | 586 | 585 | 602 | 638 | 776 | 820 | 957 | 908 | 935 | 1,024 | 1,224 |
| Income from operations | 294 | 355 | 405 | 409 | 429 | 426 | 542 | 579 | 810 | 904 | 1,000 | 1,132 |
| Interest (expense) income, net | - | - | - | - | - | - | - | - | - | - | -22 | -47 |
| Income (Loss) from Equity Method Investments | - | - | - | - | - | - | - | -16 | -25 | -11 | -8 | -7 |
| Equity Securities, FV-NI, Gain (Loss) | - | - | - | - | - | - | - | - | - | - | -12 | 10 |
| Gain on insurance recoveries | - | - | - | - | - | - | - | - | - | - | - | 20 |
| Other, net | 8 | -2 | 1 | 6 | 5 | 4 | -9 | -11 | -12 | 15 | 3 | -6 |
| Total other income (loss), net | 38 | 30 | 26 | 27 | 11 | -7 | -21 | -60 | -77 | -20 | -40 | -30 |
| Income before income taxes | 332 | 385 | 431 | 436 | 440 | 419 | 521 | 519 | 733 | 884 | 960 | 1,102 |
| Income taxes (note 12) | 77 | 78 | 86 | 83 | 87 | 76 | 206 | 114 | 111 | 409 | 181 | 204 |
| Net income | 255 | 307 | 345 | 353 | 352 | 342 | 316 | 405 | 622 | 475 | 779 | 898 |
| Earnings Per Share, Basic | 1.75 | 2.15 | 2.44 | 2.51 | 2.51 | 2.42 | 2.21 | 2.83 | 4.31 | 3.27 | 5.34 | 6.12 |
| Earnings Per Share, Diluted | 1.71 | 2.1 | 2.39 | 2.47 | 2.49 | 2.4 | 2.19 | 2.8 | 4.27 | 3.24 | 5.3 | 6.09 |
| Common Stock, Dividends, Per Share, Declared | - | 0.68 | 1 | 1.12 | 1.2 | 1.32 | 1.4 | 1.48 | 1.56 | 1.56 | 1.68 | 1.76 |